Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Incyte Corporation
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Novartis
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
University of Michigan Rogel Cancer Center
MPN Research Foundation